Skip to main content
. Author manuscript; available in PMC: 2014 Oct 20.
Published in final edited form as: Brain Res. 2001 Feb 2;890(2):222–232. doi: 10.1016/s0006-8993(00)03163-2

Fig. 8.

Fig. 8

The CaM kinase inhibitor KN62 (30 μM) blocks KCl-, FPL 64176-, and glutamate-mediated Ser133 CREB phosphorylation in striatal culture. (A) Ser133 CREB phosphorylation (P-CREB) and CREB levels (CREB) in KCl (20 mM)-treated primary striatal cultures. (B) Ser133 CREB phosphorylation (P-CREB) and CREB levels (CREB) in FPL 64176 (20 μM)-treated primary striatal cultures. (C) Ser133 CREB phosphorylation in glutamate (50 μM)-treated primary striatal cultures. All treatments are shown in duplicate. All experiments were repeated at least once.